Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Pro Medicus Limited (AU:PME)
ASX:PME
Holding AU:PME?
Track your performance easily
See the Price Targets and Ratings of:
PME Analyst Ratings
Moderate Buy
3 Buy
2 Hold
1 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
PME Stock 12 Month Forecast
Average Price Target
AU$240.50
▼(-4.56% Downside)
| Highest Price TargetAU$300.00 | Average Price TargetAU$240.50 | Lowest Price TargetAU$140.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
Morgan Stanley
Initiated
12/16/24
Goldman Sachs
Reiterated
12/12/24
Wilsons
Reiterated
11/29/24
RBC Capital
Reiterated
11/28/24
CLSA
Reiterated
10/09/24
MA Financial Group
Reiterated
08/19/24
Jefferies
Reiterated
08/16/24
Macquarie
Reiterated
08/15/24
J.P. Morgan
Downgraded
08/15/24
Morgans
Reiterated
08/15/24
Citi
AU$80
Sell
-68.25%
Downside
Reiterated
03/06/24
Analysts Offer Insights on Healthcare Companies: Pro Medicus Limited (Other OTC: PMCUF) and Ramsay Health Care (Other OTC: RMSYF)
Bell Potter
AU$75
Sell
-70.24%
Downside
Downgraded
02/16/24
Analysts Conflicted on These Healthcare Names: CSL (Other OTC: CMXHF), Pro Medicus Limited (Other OTC: PMCUF) and Ultragenyx Pharmaceutical (NASDAQ: RARE)
―
Ord Minnett
―
Sell
―
Reiterated
11/29/24
Best Analysts Covering Pro Medicus Limited
Which Analyst Should I Follow If I Want to Buy AU:PME and Sell After:
1 Month
xxx
Success Rate
6/7 ratings generated profit
Average Return
+9.87%
reiterated a xxx
rating 10 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 85.71% of your transactions generating a profit, with an average return of +9.87% per trade.
3 Months
xxx
Success Rate
6/7 ratings generated profit
Average Return
+25.69%
reiterated a xxx
rating 10 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 85.71% of your transactions generating a profit, with an average return of +25.69% per trade.
1 Year
Success Rate
6/7 ratings generated profit
Average Return
+56.17%
reiterated a buy rating 10 days ago
Copying Annabel Li's trades and holding each position for 1 Year would result in 85.71% of your transactions generating a profit, with an average return of +56.17% per trade.
2 Years
xxx
Success Rate
6/7 ratings generated profit
Average Return
+56.17%
reiterated a xxx
rating 10 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 85.71% of your transactions generating a profit, with an average return of +56.17% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
PME Analyst Recommendation Trends
Rating
Aug 24
Sep 24
Oct 24
Nov 24
Dec 24
Strong Buy
5
4
5
2
2
Buy
0
0
1
2
2
Hold
9
8
9
4
4
Sell
1
1
0
1
1
Strong Sell
1
0
0
0
0
total
16
13
15
9
9
Each month's total comprises the sum of three months' worth of ratings.
PME Financial Forecast
PME Stock Forecast FAQ
What is AU:PME’s average 12-month price target, according to analysts?
Based on analyst ratings, Pro Medicus Limited’s 12-month average price target is AU$240.50.
What is AU:PME’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for AU:PME, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Pro Medicus Limited a Buy, Sell or Hold?
Pro Medicus Limited has a consensus rating of Moderate Buy, which is based on 3 buy ratings, 2 hold ratings and 1 sell ratings.
What is Pro Medicus Limited’s share price target?
The average share price target for Pro Medicus Limited is AU$240.50. This is based on 6 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is AU$300.00 ,and the lowest forecast is AU$140.00. The average share price target represents -4.56% Decrease from the current price of AU$251.99.
The highest analyst share price target is AU$300.00 ,and the lowest forecast is AU$140.00. The average share price target represents -4.56% Decrease from the current price of AU$251.99.
What do analysts say about Pro Medicus Limited?
Pro Medicus Limited’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 6 Wall Streets Analysts.
How can I buy shares of Pro Medicus Limited?
To buy shares of AU:PME, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.